Burcar Alison Brummett is President & VP at ICU MEDICAL INC/DE (ICUI). They have made 14 open-market trades across 1 company since 2007, most recently 2014-02-01.
CIK 0001189727
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $50K since 2008, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ICUI | 1,907 | $311K |
Shares reported on the most recent Form 4, priced at the 2014-02-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ICUI | SELL | 2013-11-20 | 2013-11-20 | $63.05 | $977K | -10.5% | -5.2% | -5.2% |
| ICUI | SELL | 2013-11-14 | 2013-11-14 | $62.26 | $623K | -10.5% | -5.2% | -5.2% |
| ICUI | SELL | 2013-10-24 | 2013-10-28 | $63.74 | $3.7M | -10.5% | -5.2% | -5.2% |
| ICUI | SELL | 2012-02-29 | 2012-03-01 | $45.86 | $11K | -10.5% | -5.2% | -5.2% |
| ICUI | SELL | 2011-08-24 | 2011-08-24 | $39.37 | $13K | -10.5% | -5.2% | -5.2% |
| ICUI | SELL | 2010-10-27 | 2010-10-28 | $37.05 | $426K | -10.5% | -5.2% | -5.2% |
| ICUI | SELL | 2010-03-10 | 2010-03-10 | $35.72 | $33K | -10.5% | -5.2% | -5.2% |
| ICUI | BUY | 2009-08-14 | 2009-08-17 | $28.53 | $7K | -10.5% | -5.2% | -5.2% |
| ICUI | SELL | 2009-02-19 | 2009-02-19 | $35.61 | $22K | -10.5% | -5.2% | -5.2% |
| ICUI | BUY | 2009-02-13 | 2009-02-17 | $26.29 | $16K | -10.5% | -5.2% | -5.2% |
| ICUI | SELL | 2008-11-07 | 2008-11-07 | $32.87 | $38K | -10.5% | -5.2% | -5.2% |
| ICUI | BUY | 2008-08-15 | 2008-08-18 | $23.39 | $19K | -10.5% | -5.2% | -5.2% |
| ICUI | BUY | 2008-02-15 | 2008-02-19 | $23.32 | $8K | -10.5% | -5.2% | -5.2% |
| ICUI | SELL | 2007-11-13 | 2007-11-14 | $38.60 | $232K | -10.5% | -5.2% | -5.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.